CARB-X supports BioVersys in the fight against antimicrobial resistance with up to almost 9 million dollars
BioVersys receives CARB-X Award of up to US$ 8.92 Million for Development of Novel Antimicrobial Therapies:
Versameb raises CHF 6 million and strengthens team to advanc...
ARTIDIS First Prospective Study, "NANO”, Evaluating its Na...
Technologiepark Basel on Swiss national TV
Register now for "Startup MATCHER"
Bioversys on Swiss national TV